Yüklüyor......
PFKFB3 Inhibition Impairs Erlotinib-Induced Autophagy in NSCLCs
Tyrosine kinase inhibitors (TKIs) targeting the kinase domain of the epidermal growth factor receptor (EGFR), such as erlotinib, have dramatically improved clinical outcomes of patients with EGFR-driven non-small cell lung carcinomas (NSCLCs). However, intrinsic or acquired resistance remains a clin...
Kaydedildi:
| Yayımlandı: | Cells |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8307619/ https://ncbi.nlm.nih.gov/pubmed/34359849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10071679 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|